July 28, 2023 Comments Off on New patent for Janssen Biotech drug BALVERSA Posted in: Patent Added Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Janssen Biotech drug BALVERSA appeared first on Dr…
July 28, 2023 Comments Off on Pharmaceutical companies with the most orphan drugs Posted in: Infographic Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
